Fundraising Fox

Frank Yan

Investor

Partner at 3E Bioventures Capital

Shanghai

Writes $100K – $5M checks Β· typically $1.5M

Experience

  1. 3E Bioventures CapitalPartnercurrent2018 β€” present
  2. Larkspur BiosciencesBoard Directorcurrent2022 β€” present
  3. Myro TherapeuticsBoard Directorcurrent2021 β€” present
  4. Lysoway TherapeuticsBoard Directorcurrent2021 β€” present
  5. Cullgen Inc.Board Directorcurrent2020 β€” present
  6. Regenacy Pharmaceuticals, Inc.Board Directorcurrent2020 β€” present
  7. N.B. Quadriga (NBQ)Chief Executive Officercurrent2018 β€” present
  8. C4 Therapeutics, Inc.Board Observer2020
  9. GSKExternal Alliance and Partnership of Global Neurosciences Therapeutic Area2017 β€” 2018Shanghai, China
  10. RocheHead of Molecular Design and Chemical Biology2013 β€” 2017Shanghai, China
  11. RocheHead of China External Alliance2012 β€” 2013Shanghai, China
  12. RocheHead of Molecular Design and Biostructure2008 β€” 2012Shanghai City, China
  13. NovartisResearch Investigator II2003 β€” 2008San Diego County, California, United States

Education

  1. New York UniversityPh.D., Biochemistry1998 β€” 2003
  2. Fudan UniversityB.Sc., Physics1993 β€” 1997

Skills & more

Drug Discovery15Venture CapitalEntrepreneurshipDrug Development1External Innovation2Alliance Management1Business Development2Pharmaceutical Industry3Drug Design21Clinical DevelopmentProtein Chemistry5Chemical Biology1
+9 moreMolecular ModelingCheminformaticsBioinformaticsData MiningComputational ChemistryBiochemistryInfectious DiseasesOncologyLife Sciences

Languages Chinese Β· English

From Frank's professional profile.

Same school

Shared employers

Colleagues at 3E Bioventures Capital